Back to Search Start Over

Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery.

Authors :
Singh RP
Sharma G
Sonali
Singh S
Bharti S
Pandey BL
Koch B
Muthu MS
Source :
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2017 Aug 01; Vol. 77, pp. 446-458. Date of Electronic Publication: 2017 Mar 27.
Publication Year :
2017

Abstract

The aim of this work was to formulate chitosan-folate conjugated multi-walled carbon nanotubes for the lung cancer targeted delivery of docetaxel. The chitosan-folate conjugate was synthesized and the conjugation was confirmed by Fourier transform infrared spectroscopy. The multi-walled carbon nanotubes were characterized for their particle size, polydispersity, zeta potential, surface morphology, drug encapsulation efficiency and in vitro release study. The in vitro cellular uptake, cytotoxicity, and cell cycle analysis of the docetaxel/coumarin-6 loaded multi-walled carbon nanotubes were carried out to compare the effectiveness of the formulations. The biocompatibility and safety of chitosan-folate conjugated multi-walled carbon nanotubes was analyzed by lung histopathology in comparison with marketed docetaxel formulation (Docelâ„¢) and acylated multi-walled carbon nanotubes. The cellular internalization study shown that the chitosan-folate conjugated multi-walled carbon nanotubes could be easily internalized into the lung cancer cells through a folate receptor-mediated endocytic pathway. The IC <subscript>50</subscript> values exhibited that chitosan-folate conjugated multi-walled carbon nanotubes could be 89-fold more effective than Docelâ„¢ in human lung cancer cells (A549 cells).<br /> (Copyright © 2017 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-0191
Volume :
77
Database :
MEDLINE
Journal :
Materials science & engineering. C, Materials for biological applications
Publication Type :
Academic Journal
Accession number :
28532051
Full Text :
https://doi.org/10.1016/j.msec.2017.03.225